Suppr超能文献

急诊科初始乳酸水平与感染性休克患儿血管活性药物使用之间的关联

Association Between Initial Emergency Department Lactate and Use of Vasoactive Medication in Children With Septic Shock.

作者信息

Miescier Michael J, Lane Roni D, Sheng Xiaoming, Larsen Gitte Y

机构信息

From the Division of Pediatric Emergency Medicine, Department of Pediatrics.

Department of Pediatrics, and.

出版信息

Pediatr Emerg Care. 2019 Jul;35(7):455-460. doi: 10.1097/PEC.0000000000000981.

Abstract

OBJECTIVES

Current guidelines emphasize early recognition of pediatric septic shock using clinical examination findings. Elevated serum lactate has been associated with increased mortality in adult patients with septic shock. Our objective was to determine the association between the initial serum lactate obtained in the pediatric emergency department (PED) from patients treated for septic shock and the use of vasoactive medication within 24 hours.

METHODS

This was a retrospective study from 2008 through 2012 of PED patients at a tertiary care children's hospital. Patients younger than 18 years treated for septic shock were included if they had a serum lactate obtained in the PED.

RESULTS

Eight hundred sixty-four PED encounters met inclusion criteria. Median initial PED lactate was 2.1 mmol/L (interquartile range, 1.4-3.2 mmol/L). Overall, 121 patients (14%) received vasoactive medication within 24 hours of the initial PED lactate. A multivariable logistic regression analysis demonstrated associations between initial lactate levels of 3.1 to 5 mmol/L (odds ratio, 1.82; 95% confidence interval, 1.02-3.26) and 5.1 mmol/L or greater (odds ratio, 5.00; 95% confidence interval, 2.56-9.76) and the use of vasoactive medication within 24 hours. Other factors associated with use of vasoactive medication within 24 hours included hypotension, abnormal pulses, and mental status changes.

CONCLUSIONS

Increased initial lactate is associated with use of vasoactive medication within 24 hours in PED patients with septic shock.

摘要

目的

当前指南强调利用临床检查结果早期识别儿童感染性休克。血清乳酸水平升高与成年感染性休克患者死亡率增加相关。我们的目的是确定在儿科急诊科(PED)接受感染性休克治疗的患者初始血清乳酸水平与24小时内使用血管活性药物之间的关联。

方法

这是一项对一家三级儿童专科医院2008年至2012年PED患者的回顾性研究。纳入在PED接受感染性休克治疗且有血清乳酸检测值的18岁以下患者。

结果

864次PED就诊符合纳入标准。PED初始乳酸水平中位数为2.1 mmol/L(四分位间距,1.4 - 3.2 mmol/L)。总体而言,121例患者(14%)在初始PED乳酸检测后24小时内接受了血管活性药物治疗。多变量逻辑回归分析显示,初始乳酸水平在3.1至5 mmol/L(比值比,1.82;95%置信区间,1.02 - 3.26)以及5.1 mmol/L或更高(比值比,5.00;95%置信区间,2.56 - 9.76)与24小时内使用血管活性药物相关。与24小时内使用血管活性药物相关的其他因素包括低血压、脉搏异常和精神状态改变。

结论

感染性休克的PED患者中,初始乳酸水平升高与24小时内使用血管活性药物相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验